Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 99 Show results per page	View Search Criteria \| Help With Results

	Title				Phase				Protocol IDs

	Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis				Phase III, Phase II				20050113 NCT00243685
	Testing Drug Sensitivity of Ovarian, Fallopian and Primary Peritoneal Adenocarcinomas				Phase III, Phase II				WIRB 20060042 NCT00443196
	Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer				Phase III				GOG-0212 NCT00108745
	Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer				Phase III				GOG-0218 NCT00262847
	OVATURE (OVArian TUmor REsponse) Study: A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer				Phase III				NV06-0039 NCT00382811
	Karenitecin Versus Topotecan in Patients With Advanced Epithelial Ovarian Cancer				Phase III				KTN32313R NCT00477282
	Pentostatin and Donor White Blood Cells in Preventing Graft Rejection in Cancer Patients Who Have Undergone Donor Stem Cell Transplantation				Phase II, Phase I				FHCRC-1825.00 5605, SUPERGEN-FHCRC-1825.00, NCT00096161
	Ixabepilone and Liposomal Doxorubicin in Treating Women With Advanced Ovarian Epithelial, Peritoneal Cavity, or Fallopian Tube Cancer or Metastatic Breast Cancer				Phase II, Phase I				AECM-0504007857 NCI-7229, 7229, NCT00182767
	Allogeneic Transplantation From Related Haploidentical Donors in Older Patients With Indolent Hematologic Malignancies				Phase II, Phase I				BMT124 75117, BMT124, NCT00185692, NCT00185692
	Docetaxel With or Without Phenoxodiol in Treating Patients With Recurrent Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer				Phase II, Phase I				YALE-HIC-27640 YALE-012705, NCT00303888


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute